Patient Preference and Adherence to Aminosalicylates for the Treatment of Ulcerative Colitis

Ulcerative colitis (UC) is a chronic inflammatory disorder that requires sustained treatment for optimal outcomes. The 5-aminosalicylate (5-ASA) class of medications are first-line for the treatment of mild-to-moderate UC but suffer from suboptimal adherence rates in real-world settings. This review...

Descripción completa

Detalles Bibliográficos
Autores principales: Tripathi, Kartikeya, Dong, Jeffrey, Mishkin, Brooke F, Feuerstein, Joseph D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412827/
https://www.ncbi.nlm.nih.gov/pubmed/34511961
http://dx.doi.org/10.2147/CEG.S237653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412827/
https://www.ncbi.nlm.nih.gov/pubmed/34511961
http://dx.doi.org/10.2147/CEG.S237653

Ejemplares similares